National Hemophilia Foundation Judith Graham Poole Postdoctoral Research Fellowship
Letter of Intent Deadline: November 23, 2010
Application Deadline: February 23, 2011
Award Start Date: July 1, 2011
The program is named for Dr. Judith Graham Pool. In 1965, Dr. Pool discovered a simple method of extracting the clotting factor from human plasma. This opened the door to a series of rapid developments that revolutionized the treatment of hemophilia including replacement therapy. Replacement therapy (i.e., the infusion of the missing clotting factor to prevent or stop bleeding) has made it possible for people with hemophilia to live relatively normal and productive lives and to avoid, in large measure, the potentially crippling effects of the disorder.
Only noncommercial institutions and investigators associated with a noncommercial institution are eligible for NHF funding.
All grant and fellowship applications are subjected to a rigorous peer review process. Applications are critiqued on scientific merit and relevance to NHF research priorities. Applications are reviewed and scored in terms of significance, approach, innovation, investigator, and environment. A panel selected by the Research Working Group, a volunteer group of scientific and lay leaders, reviews applications received.
Eligibility
Applicants must have completed doctoral training and must enter the JGP fellowship program from a doctoral, postdoctoral, internship or residency training program. Established investigators or faculty members are not eligible. Applicants must be affiliated with domestic organizations such as universities, colleges, hospitals and laboratories. US citizenship is not required.
Permissible research topics include clinical or basic research on the biochemical, genetic, hematologic, orthopedic, psychiatric or dental aspects of the hemophilias or von Willebrand disease. Other topics include rehabilitation, therapeutic modalities, psychosocial issues, women's health issues, liver disease, or AIDS/HIV as they pertain to the hemophilias or von Willebrand disease.
It is expected that the fellow will spend at least 90% of the time on the research project for which funding is requested. The remaining 10% may be devoted to teaching or clinical work that is relevant to the research.
Funding
Support is available for up to $42,000/per year for a maximum of two years (pending continuing grant approval).
Letter of Intent
All interested candidates must submit a letter of intent by 5pm EST, November 23, 2010. This should be a brief letter identifying the researcher, their mentor, institution and a description of the proposed research project. Letters of intent should include an NIH-style CV or biosketch for both candidate and mentor. Letters of intent will be evaluated by members of NHF's Research Review Committee who will collectively decide upon the candidates invited to submit a full JGP application.
Inquiries
For further information, contact:
Angelina Wang
Director of Research and Medical Information
116 West 32nd Street, 11th floor
New York, NY 10001
Phone: (212) 328-3727 or (800) 42-HANDI ext. 3727
Fax: (212) 328-3799
E-mail: awang@hemophilia.org
